Matches in SemOpenAlex for { <https://semopenalex.org/work/W2133896329> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2133896329 endingPage "1326???1333" @default.
- W2133896329 startingPage "1326???1333" @default.
- W2133896329 abstract "Idiopathic facial nerve paralysis (IFNP) is a common malady. Because its etiology is unclear, there are a variety of treatment options. Studies to date have not clearly established the benefits of treatment with oral steroids (prednisone). The authors performed a randomized double-blind controlled study comparing the use of placebo versus prednisone which shows that prednisone-treated patients benefit from early treatment. Seventy-six patients met inclusion criteria and completed follow-up until recovery; 35 patients received prednisone and 41 received placebo. Their mean age was 36.8 years. Facial nerve function was assessed using the House-Brackmann facial nerve grading scale, as well as a variety of other measures. Patients were evaluated pretreatment, regularly post-treatment until judged recovered (return of facial function to a grade III or better), and at 6 months after recovery. Difference in mean time to resolution for the prednisone (51.4 days) and placebo (69.3 days) groups was not statistically significant. There was a significant difference in grade at recovery, with the placebo group having a higher proportion of grade III results (P < .03). Eight of 10 patients with electroneurography (ENOG) evidence of denervation were in the placebo group and accounted for 6 of the 7 grade III results. However, the difference in proportion of patients with evidence of denervation for the prednisone (5.7%) and placebo (19.5%) groups did not achieve statistical significance. This study shows that patients treated with prednisone have less denervation than placebo-treated patients. They also have a significant improvement in facial grade at recovery compared to placebo-treated patients. Therefore, the authors recommend that all patients at risk for developing denervation receive prednisone treatment." @default.
- W2133896329 created "2016-06-24" @default.
- W2133896329 creator A5006523433 @default.
- W2133896329 creator A5058355803 @default.
- W2133896329 creator A5060442956 @default.
- W2133896329 creator A5083437286 @default.
- W2133896329 date "1993-12-01" @default.
- W2133896329 modified "2023-10-18" @default.
- W2133896329 title "Idiopathic Facial Nerve Paralysis" @default.
- W2133896329 doi "https://doi.org/10.1288/00005537-199312000-00002" @default.
- W2133896329 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8246650" @default.
- W2133896329 hasPublicationYear "1993" @default.
- W2133896329 type Work @default.
- W2133896329 sameAs 2133896329 @default.
- W2133896329 citedByCount "82" @default.
- W2133896329 countsByYear W21338963292012 @default.
- W2133896329 countsByYear W21338963292013 @default.
- W2133896329 countsByYear W21338963292014 @default.
- W2133896329 countsByYear W21338963292015 @default.
- W2133896329 countsByYear W21338963292016 @default.
- W2133896329 countsByYear W21338963292018 @default.
- W2133896329 countsByYear W21338963292020 @default.
- W2133896329 countsByYear W21338963292021 @default.
- W2133896329 countsByYear W21338963292022 @default.
- W2133896329 crossrefType "journal-article" @default.
- W2133896329 hasAuthorship W2133896329A5006523433 @default.
- W2133896329 hasAuthorship W2133896329A5058355803 @default.
- W2133896329 hasAuthorship W2133896329A5060442956 @default.
- W2133896329 hasAuthorship W2133896329A5083437286 @default.
- W2133896329 hasConcept C126322002 @default.
- W2133896329 hasConcept C137627325 @default.
- W2133896329 hasConcept C141071460 @default.
- W2133896329 hasConcept C142724271 @default.
- W2133896329 hasConcept C204787440 @default.
- W2133896329 hasConcept C27081682 @default.
- W2133896329 hasConcept C2776805190 @default.
- W2133896329 hasConcept C2778720950 @default.
- W2133896329 hasConcept C2778987478 @default.
- W2133896329 hasConcept C2779618896 @default.
- W2133896329 hasConcept C2781019609 @default.
- W2133896329 hasConcept C42219234 @default.
- W2133896329 hasConcept C71924100 @default.
- W2133896329 hasConcept C80782408 @default.
- W2133896329 hasConceptScore W2133896329C126322002 @default.
- W2133896329 hasConceptScore W2133896329C137627325 @default.
- W2133896329 hasConceptScore W2133896329C141071460 @default.
- W2133896329 hasConceptScore W2133896329C142724271 @default.
- W2133896329 hasConceptScore W2133896329C204787440 @default.
- W2133896329 hasConceptScore W2133896329C27081682 @default.
- W2133896329 hasConceptScore W2133896329C2776805190 @default.
- W2133896329 hasConceptScore W2133896329C2778720950 @default.
- W2133896329 hasConceptScore W2133896329C2778987478 @default.
- W2133896329 hasConceptScore W2133896329C2779618896 @default.
- W2133896329 hasConceptScore W2133896329C2781019609 @default.
- W2133896329 hasConceptScore W2133896329C42219234 @default.
- W2133896329 hasConceptScore W2133896329C71924100 @default.
- W2133896329 hasConceptScore W2133896329C80782408 @default.
- W2133896329 hasIssue "12" @default.
- W2133896329 hasLocation W21338963291 @default.
- W2133896329 hasLocation W21338963292 @default.
- W2133896329 hasOpenAccess W2133896329 @default.
- W2133896329 hasPrimaryLocation W21338963291 @default.
- W2133896329 hasRelatedWork W1998855944 @default.
- W2133896329 hasRelatedWork W2003701348 @default.
- W2133896329 hasRelatedWork W2119608662 @default.
- W2133896329 hasRelatedWork W2133896329 @default.
- W2133896329 hasRelatedWork W2324099240 @default.
- W2133896329 hasRelatedWork W2441361021 @default.
- W2133896329 hasRelatedWork W2782558864 @default.
- W2133896329 hasRelatedWork W3029068912 @default.
- W2133896329 hasRelatedWork W4361249948 @default.
- W2133896329 hasRelatedWork W82934264 @default.
- W2133896329 hasVolume "103" @default.
- W2133896329 isParatext "false" @default.
- W2133896329 isRetracted "false" @default.
- W2133896329 magId "2133896329" @default.
- W2133896329 workType "article" @default.